These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 300112)

  • 1. Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses.
    Burton RC; Warner NL
    J Natl Cancer Inst; 1977 Mar; 58(3):701-9. PubMed ID: 300112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor immunity to murine plasma cell tumors. V. Genetic control of the in vitro cytotoxic T-cell response to plasma cell tumor-associated antigens of NZB mice.
    Burton RC; Warner NL
    J Natl Cancer Inst; 1980 Aug; 65(2):431-40. PubMed ID: 6967529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro induction of tumor-specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activated in vitro to oncofetal and plasmacytoma antigens.
    Burton RC; Chism SE; Warner NL
    J Immunol; 1977 Mar; 118(3):971-80. PubMed ID: 300394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor immunity to murine plasma cell tumours. Influence of responder genotype on the specificity of the immune response to plasmacytomas and T lymphomas.
    Burton RC; Warner NL
    Aust J Exp Biol Med Sci; 1978 Oct; 56(5):587-95. PubMed ID: 751633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro induction of tumor-specific immunity. II. Activation of cytotoxic lymphocytes to murine oncofetal antigens.
    Chism SE; Burton RC; Warner NL
    J Natl Cancer Inst; 1976 Aug; 57(2):377-87. PubMed ID: 63560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.
    Röllinghoff M; Rouse BT; Warner NL
    J Natl Cancer Inst; 1973 Jan; 50(1):159-72. PubMed ID: 4571237
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors.
    Wagner H; Röllinghoff M
    J Exp Med; 1973 Jul; 138(1):1-15. PubMed ID: 4541509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
    Toffaletti DL; Darrow TL; Scott DW
    J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor immunity to murine plasma cell tumors. VII. Expression of H-2 and tumor antigens on Ig synthesis variants of MPC-11.
    Giorgi JV; Burton RC; Scott D; Warner NL
    Int J Cancer; 1982 Jan; 29(1):119-26. PubMed ID: 6977499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of murine cytotoxic T cell precursors reactive to plasma cell tumour-associated antigens as compared to major histocompatibility antigens.
    Burton RC
    Aust J Exp Biol Med Sci; 1986 Aug; 64 ( Pt 4)():323-34. PubMed ID: 3491597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous cytotoxic T cell lines reactive against murine plasmacytoma tumor-associated antigens.
    Giorgi JV; Warner NL
    J Immunol; 1981 Jan; 126(1):322-30. PubMed ID: 6161166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immunity in vitro against syngeneic mouse plasma tumour cells.
    Wagner H; Röllinghoff M
    Nat New Biol; 1973 Jan; 241(106):53-4. PubMed ID: 4540590
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitory effect of tumor-bearing state on the generation of in vivo protective immune T cells in a syngeneic murine tumor system.
    Fujiwara H; Hamaoka T; Nishino Y; Kitagawa M
    Gan; 1977 Oct; 68(5):589-601. PubMed ID: 73490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated immunity against particulate and solubilized tumor-associated antigens of murine plasmacytomas detected by macrophage migration inhibition assays.
    Padarathsingh ML; Dean JH; McCoy JL; Lewis DD; Northing JW; Natori T; Law LW
    Int J Cancer; 1977 Oct; 20(4):624-31. PubMed ID: 914399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E; Bonavida B
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro induction of tumour-specific immunity V. Detection of common antigenic determinatnts of murine fibrosarcomas.
    Burton RC; Warner NL
    Br J Cancer; 1978 Feb; 37(2):159-70. PubMed ID: 75739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response.
    Rouse BT; Röllinghoff M; Warner NL
    Eur J Immunol; 1973 Apr; 3(4):218-24. PubMed ID: 4541468
    [No Abstract]   [Full Text] [Related]  

  • 20. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
    Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
    J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.